J&J Makes Executive Changes
By

Johnson & Johnson (J&J) has announced the appointment of several senior leaders to the company’s Executive Committee. The move includes the appointment of Joaquin Duato, Executive Vice President, Worldwide Chairman, Pharmaceuticals, to the position of Vice Chairman of the Executive Committee, where he will be responsible for both the Pharmaceuticals and Consumer sectors of the company. 

Specifically, Joaquin Duato, Executive Vice President, Worldwide Chairman, Pharmaceuticals, has been appointed to the position of Vice Chairman of the Executive Committee, effective July 2, 2018. In his role as Vice Chairman of the Executive Committee, Mr. Duato will be responsible for the Pharmaceuticals and Consumer sectors, as well as Supply Chain, Information Technology, Global Services, and the Health and Wellness businesses. He will continue to report to Alex Gorsky, Chairman of the Board and Chief Executive Officer of Johnson & Johnson.

Dr. Paul Stoffels, Executive Vice President, Chief Scientific Officer of Johnson & Johnson, has been appointed to the position of Vice Chairman of the Executive Committee, effective July 2, 2018. In his role as Vice Chairman of the Executive Committee, Dr. Stoffels will be responsible for Pharmaceutical Research & Development, Global Public Health, the Office of the Chief Medical Officer, External Innovation, Pharmaceuticals Business Development and Healthcare Technology. He will continue to report to Alex Gorsky, Chairman of the Board and Chief Executive Officer of Johnson & Johnson.

In other moves, Jennifer Taubert, Company Group Chairman, The Americas, Pharmaceuticals, has been appointed Executive Vice President, Worldwide Chairman, Pharmaceuticals and named to the Executive Committee, effective July 2, 2018.  She will report to Mr. Duato.

Kathy Wengel, Worldwide Vice President, Johnson & Johnson Supply Chain, has been appointed Executive Vice President, Chief Global Supply Chain Officer, and named to the Executive Committee, effective July 2, 2018.  She will report to Mr. Duato.

Ashley McEvoy, Company Group Chairman, Consumer Medical Devices, has been appointed Executive Vice President, Worldwide Chairman, Medical Devices, effective July 2, 2018.  She will report to Mr. Gorsky and become a member of the Executive Committee.

Michael Sneed, Worldwide Vice President, Global Corporate Affairs and Chief Communication Officer, will become Executive Vice President, Global Corporate Affairs and Chief Communication Officer and a member of the Executive Committee, effective July 2, 2018.  Mr. Sneed will also assume responsibility for the Global Design group.  He will continue to report to Mr. Gorsky.

Separately, the company announced the retirement of Sandra (Sandi) E. Peterson, Group Worldwide Chairman, effective October 1, 2018. Ms. Peterson joined Johnson & Johnson in December of 2012. Prior to joining the company, she was Chairman and  Chief Executive Officer of Bayer CropScience AG in Germany. She had previously served as CEO of Bayer Medical Care and president of Bayer HealthCare AG’s Diabetes Care Division. Earlier, she held leadership roles at Medco Health Solutions (previously known as Merck-Medco), Nabisco, Whirlpool Corporation, and McKinsey & Company.

In addition, as previously announced, Joseph Wolk, Vice President of Johnson & Johnson Investor Relations, has been appointed Executive Vice President, Chief Financial Officer and a member of the Executive Committee effective July 1, 2018.

Source: Johnson & Johnson (Executive Appointments) and Johnson & Johnson (Sandra Peterson retirement)

Leave a Reply

Your email address will not be published.